LYMErix Product Liability Suit Seeks Testing For OspA Sensitivity

A product liability lawsuit is arguing that SmithKline Beecham's LYMErix vaccine should be used only in patients that have been tested for sensitivity to the outer surface protein A Lyme disease vaccine.